These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21466494)

  • 21. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
    Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veterans Affairs Health Care System.
    Khan N; Abbas AM; Moehlen M; Balart L
    Inflamm Bowel Dis; 2013 Jun; 19(7):1379-83. PubMed ID: 23542534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S; Noble A; Deslandres C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
    Paoluzi OA; Pica R; Marcheggiano A; Crispino P; Iacopini F; Iannoni C; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1751-9. PubMed ID: 12269968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
    Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial.
    Oren R; Arber N; Odes S; Moshkowitz M; Keter D; Pomeranz I; Ron Y; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Bardan E; Villa Y; Gilat T
    Gastroenterology; 1996 May; 110(5):1416-21. PubMed ID: 8613046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
    Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary Management of Ulcerative Colitis.
    Vanga R; Long MD
    Curr Gastroenterol Rep; 2018 Mar; 20(3):12. PubMed ID: 29589185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
    Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
    Colombel JF; Sandborn WJ; Reinisch W; Peyrin-Biroulet L; Panaccione R; Rutgeerts P; Hanauer SB; Ghosh S; Van Assche G; Robinson AM; Lau W; Maa JF; Huang B; Pappalardo B; Read H
    Aliment Pharmacol Ther; 2018 Jan; 47(2):219-228. PubMed ID: 29159817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis.
    Egan LJ; Sandborn WJ; Tremaine WJ; Leighton JA; Mays DC; Pike MG; Zinsmeister AR; Lipsky JJ
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1597-604. PubMed ID: 10594394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
    Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.